Page 834 - ACCCN's Critical Care Nursing

I N D E X 811

contingency plans and rehearsal 30 scales 139, 141t SIMV see synchronised intermittent mandatory
managing injury - staff, patient or visitor VICS for 139, 140f, 141t ventilation
29–30, 29b Sedation-Agitation Scale (SAS) 141t single photon emission computed tomography
negligence 28–29 sedative-hypnotic agent 136t (SPECT), of cerebral perfusion 436
research vignette 34b sedatives single-lung transplantation (SLTx) 370
role of leadership and management 29 benzodiazepine 136t sinoatrial (SA) node 184–185
RMs see recruitment manoeuvres for intracranial hypertension and atria arrhythmias 252–254, 253f
roller pump 495, 495f management 453 sinus arrest 253–254, 254f
root cause analysis (RCA) 30, 788 non-benzodiazepine 136t sinus arrhythmia 253, 254f
ROSC see return of spontaneous circulation SEE see Sentinel Events Evaluation study sinus bradycardia 253, 253f
rostering 27 seizures 446 sinus exit block 253–254, 254f
calculating staff requirements 27f in children 696–697 sinus pause 253–254, 254f
rotational therapy 114 Sellick manoeuvre 385 sinus tachycardia 252–253, 253f
RQOL see health-related quality of life Sengstaken-Blakemore tube 520–521, 522f sinus arrest 253–254, 254f
R-R intervals 195 sensing failure 272–273, 273f sinus arrhythmia 253, 254f
RRS see rapid response systems sensory control 431 sinus bradycardia 253, 253f
RRT see rapid response systems; renal sensory function alterations 446–447 sinus exit block 253–254, 254f
replacement therapy sensory overload 788 sinus pause 253–254, 254f
rule of nines 646f Sentinel Events Evaluation (SEE) study 28 sinus rhythm 252, 255f
RVEDV see right ventricular end-diastolic sepsis 551–552, 552t, 788 sinus tachycardia 252–253, 253f
volume bundle types 552b SIRS see systemic inflammatory response
RVEDVI see right ventricular end-diastolic from catheters 122 syndrome
volume index in children 682–683 SjvO 2 see jugular venous oxygenation
RVEF see right ventricular ejection fraction severe 551, 552t, 788 skeletal trauma 629–635
RVESV see right ventricular end-systolic volume EGDT in 571t fat embolism and 630
RVESVI see right ventricular end-systolic volume sepsis-induced hypotension 788 neurovascular observations in 632t
index septic shock 551–552, 788 pelvic fracture classifications 631f
RVF see right ventricular failure antimicrobial therapy for 553 rhabdomyolysis and 630
RVSWI see right ventricular stroke work clinical manifestations of 552–553 skill mix 26–27, 788
collaborative management in 553–554 skin and tissue assessment 105–107
S diagnosis of 553 skin tears 107
drug therapy for 553–554
treatment of 107t
S1 see first heart sound inotrope 554 skull fractures, TBI and 457
S2 see second heart sound recombinant human activated protein SLED see slow low efficiency dialysis
S3 see ventricular gallop C 554 sleep 145–149
S4 see late diastolic heart sound steroids 554 actigraphy and 146
SA see sinoatrial node vasopressors 554 assessment of 146, 146t
sacculated aortic aneurysm 244, 244f fluid resuscitation for 553 care activities for 147
safety 49–52 nursing practice in 553–554 comfort measures for 147
culture 50 progression of 566f environment and 147
monitoring 42–49 source control of 553 maintenance of 147–149
rapid response systems 50–52 Sequential Organ Failure Assessment (SOFA) medications for 148, 148t
afferent limb of 50–51 score 570, 570t melatonin and 149
efferent limb of 51–52 severe acute respiratory syndrome (SARS) monitoring of 146
research on 52t 360–361, 788 NOC for 146, 146t
Safety Attitudes Questionnaire (SAQ) 50 personal protective equipment and 121 non-REM 145–146
SAH see subarachnoid hemorrhage severe sepsis 551, 552t, 788 promotion of 147–149
salicylate poisoning 601–602 EGDT in 571t PSG and 145–146
saphenous vein graft (SVG) 293 SF-36 (medical outcomes study) 59–60, 59t RCSQ for 146, 146t
SAPS see simplified acute physiology score shock REM 145–146
SAQ see Safety Attitudes Questionnaire anaphylaxis see anaphylaxis SICQ for 146, 146t
SARS see severe acute respiratory syndrome cardiogenic see cardiogenic shock SWS 145–146
SARS coronavirus (SARS-CoV) 121 case study 557b treatments for 147–148
SARS-CoV see SARS coronavirus in children 695–696 TST 145–146
SAS see Sedation-Agitation Scale assessment 695–696 Sleep in Intensive Care Questionnaire
SBTs see spontaneous breathing trials clinical manifestations of 695 (SICQ) 146, 146t
SCA see sudden cardiac arrest diagnostics 695–696 slow low efficiency dialysis (SLED) 788
school-age children, developmental management of 696 slow wave sleep (SWS) 145–146
considerations in 685 distributive see distributive shock states SLTx see single-lung transplantation
Schwann cells 417, 419t effective resuscitation 571 snake bites 608–610, 609t
SCI see spinal cord injury hypovolaemic see hypovolaemic shock SNS see sympathetic nervous system
SE see status epilepticus invasive assessment for 542 SOFA see Sequential Organ Failure Assessment
seatbelt position, pregnancy and 729, 729f lactate production and 540, 541t score
second heart sound (S2) 191 management principles of 542, 542b soma 414–415, 416f
secondary brain injury, prevention of 472 neurogenic see neurogenic shock somnolence 445–446
second-degree atrioventricular block 260–261, non-invasive assessment for 541–542 space, surge plan development and 33
260f PAC and 542 Spanish influenza 361
sedation 138–141 pathophysiology of 539–541 spastic flexor 433–434
assessment of 138–140 patient assessment for 541–542 specialist critical care competencies 5
BIS monitoring 139–140 physiological changes in 541, 541t SPECT see single photon emission computed
MAAS for 141t septic see septic shock tomography
obese patients and 118 spinal see spinal shock spinal cord 428–430, 429f–430f
protocols 140–141 types of 539, 540t spinal cord injury (SCI) 457–462
Ramsay Sedation Scale for 141t SICQ see Sleep in Intensive Care Questionnaire anterior cord syndrome 460
RASS for 139, 140f, 141t simplified acute physiology score (SAPS) 26, Brown-Sêquard syndrome 460
SAS for 141t 570 central cord syndrome 460